Literature DB >> 2547513

ras oncogenes in human cancer: a review.

J L Bos1.   

Abstract

Mutations in codon 12, 13, or 61 of one of the three ras genes, H-ras, K-ras, and N-ras, convert these genes into active oncogenes. Rapid assays for the detection of these point mutations have been developed recently and used to investigate the role mutated ras genes play in the pathogenesis of human tumors. It appeared that ras gene mutations can be found in a variety of tumor types, although the incidence varies greatly. The highest incidences are found in adenocarcinomas of the pancreas (90%), the colon (50%), and the lung (30%); in thyroid tumors (50%); and in myeloid leukemia (30%). For some tumor types a relationship may exist between the presence of a ras mutation and clinical or histopathological features of the tumor. There is some evidence that environmental agents may be involved in the induction of the mutations.

Entities:  

Mesh:

Year:  1989        PMID: 2547513

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  1323 in total

1.  Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations.

Authors:  P Rieske; J Bartkowiak; A Szadowska; M Debiec-Rychter
Journal:  Mol Pathol       Date:  1999-04

2.  Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells.

Authors:  Y h Chen; Q Lu; E E Schneeberger; D A Goodenough
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

3.  Reovirus as a novel oncolytic agent.

Authors:  K L Norman; P W Lee
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Immunohistochemical Expression of N-ras Oncogene is a Late Event in Head and Neck Carcinomas.

Authors:  John S McDonald; Keith M Wilson; Peter Gartside; Robert L Sonke; Ljiljana Pavelic; Eric Okum; Julie Neanen; Jack L Gluckman; Zlatko P Pavelic
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 5.  A Ras by any other name.

Authors:  D Bar-Sagi
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Combination analysis of genetic alterations and cell proliferation in small intestinal carcinomas.

Authors:  T Muneyuki; M Watanabe; M Yamanaka; S Isaji; Y Kawarada; R Yatani
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

7.  Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway.

Authors:  S Gupta; R Plattner; C J Der; E J Stanbridge
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

8.  Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway.

Authors:  S H Hansen; M M Zegers; M Woodrow; P Rodriguez-Viciana; P Chardin; K E Mostov; M McMahon
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

9.  A preliminary study on ras protein expression in human esophageal cancer and precancerous lesions.

Authors:  Jian Li; Chang-Wei Feng; Zhi-Guo Zhao; Qi Zhou; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

10.  Controlling tumor-derived and vascular endothelial cell growth: role of the 4Ff2 cell surface antigen.

Authors:  M Papetti; I M Herman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.